| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |